Organon & Co Sustainability Reports
Organon & Co. develops, manufactures, and markets health solutions with a primary focus on women's health, biosimilars, and established medicines.
Sector: Manufacturing
Country: United States
Exchange: New York Stock Exchange
LEI: 549300AMCKY57OK2CO56
FIGI: BBG00ZQRGW42
9 reports from 2021 to 2024
